Berlin Cures Announces Formation of Scientific Advisory Board

Berlin Cures Announces Formation of Scientific Advisory Board

Inaugural Members Include Leading Experts in Cardiology and Autoimmunity ZUG, Switzerland, May 23, 2018 /PRNewswire/ — Drug developer Berlin Cures today announced the formation of a Scientific Advisory Board (SAB) and the appointment of its first two members, Prof. Beda M. Stadler and Prof. Wilhelm Vetter, to help advance